Literature DB >> 26318165

No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses.

Dimiter S Dimitrov1, Shibo Jiang2, Tianlei Ying3, Chien-Te K Tseng4, Linqi Zhang5, Kwok-Yung Yuen6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26318165      PMCID： PMC4577136          DOI： 10.1073/pnas.1513441112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.

Authors:  Kristen E Pascal; Christopher M Coleman; Alejandro O Mujica; Vishal Kamat; Ashok Badithe; Jeanette Fairhurst; Charleen Hunt; John Strein; Alexander Berrebi; Jeanne M Sisk; Krystal L Matthews; Robert Babb; Gang Chen; Ka-Man V Lai; Tammy T Huang; William Olson; George D Yancopoulos; Neil Stahl; Matthew B Frieman; Christos A Kyratsous
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

2.  Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Authors:  Tianlei Ying; Lanying Du; Tina W Ju; Ponraj Prabakaran; Candy C Y Lau; Lu Lu; Qi Liu; Lili Wang; Yang Feng; Yanping Wang; Bo-Jian Zheng; Kwok-Yung Yuen; Shibo Jiang; Dimiter S Dimitrov
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

3.  Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.

Authors:  Liwei Jiang; Nianshuang Wang; Teng Zuo; Xuanling Shi; Kwok-Man Vincent Poon; Yongkang Wu; Fei Gao; Danyang Li; Ruoke Wang; Jianying Guo; Lili Fu; Kwok-Yung Yuen; Bo-Jian Zheng; Xinquan Wang; Linqi Zhang
Journal:  Sci Transl Med       Date:  2014-04-28       Impact factor: 17.956

4.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  Infection with MERS-CoV causes lethal pneumonia in the common marmoset.

Authors:  Darryl Falzarano; Emmie de Wit; Friederike Feldmann; Angela L Rasmussen; Atsushi Okumura; Xinxia Peng; Matthew J Thomas; Neeltje van Doremalen; Elaine Haddock; Lee Nagy; Rachel LaCasse; Tingting Liu; Jiang Zhu; Jason S McLellan; Dana P Scott; Michael G Katze; Heinz Feldmann; Vincent J Munster
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823
  5 in total
  1 in total

1.  Reply to Dimitrov et al.: VelociSuite technologies are a foundation for rapid therapeutic antibody development.

Authors:  Christos A Kyratsous; William Olson; Neil Stahl
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-28       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.